Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.606, 2010-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Celecoxib and rofecoxib equally effective in knee OA
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Access to resources
Recommend
Hylan-G-F-20 for OA of the knee cost saving in US managed care
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. :
Hylan-G-F-20 for OA of the knee cost saving in US managed care
Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. :
Primary angioplasty cost effective in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 542, 2007-01 ,pp. :
Botulinum toxin A cost effective for urinary incontinence in France . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 612, 2010-01 ,pp. :